ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors
Primary Purpose
Upper Gastrointestinal Submucosal Tumors (SMTs), Gastrointestinal Stromal Tumors (GISTs), Leiomyoma
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ESTD
VATS
Sponsored by
About this trial
This is an interventional treatment trial for Upper Gastrointestinal Submucosal Tumors (SMTs) focused on measuring upper gastrointestinal submucosal tumors, SMTs, Gastrointestinal stromal tumors, GISTs, Leiomyoma, Endoscopic submucosal tunnel dissection, ESTD, Submucosal tunneling endoscopic resection, STER, Submucosal endoscopic tumor resection, SET
Eligibility Criteria
Inclusion Criteria:
- Between 18 and 75 years of age
- Patient with upper gastrointestinal submucosal tumor
- Signed informed consent
Exclusion Criteria:
- Severe cardio-pulmonary disease or other serious disease leading to unacceptable surgical risk
- Endoscopic ultrasound (EUS) or CT signs of metastasis
- Mega-oesophagus (greater than 7 cm) or Oesophageal diverticula in the distal oesophagus
- Previous oesophageal or gastric surgery
- Pregnancy or lactation women, or ready to pregnant women
- Not capable of filling out questionnaires
Sites / Locations
- Nanfang Hospital of Southern Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
ESTD
VATS
Arm Description
Endoscopic submucosal tunnel dissection (ESTD) for patients with upper gastrointestinal submucosal tumors (SMTs)
Video-assisted thoracoscopic surgery (VATS) for patients with upper gastrointestinal submucosal tumors (SMTs)
Outcomes
Primary Outcome Measures
En bloc resection
The En bloc resection was defined as a one-piece resection of the entire lesion without fragmentation
Secondary Outcome Measures
Curative resection
The curative resection was defined as the resected specimen with vertical and lateral margins free of neoplasia in pathological diagnosis.
Procedure related complication
Perforation, Delayed bleeding, Pneumothorax, Subcutaneous emphysema, Anastomotic leak, etc.
Short-term morbidity
Any cause death
Local recurrence
Local recurrence was defined as endoscopic or histological diagnosis of cancer at the resected site in follow-up
Quality of life
Patients will complete the quality-of-life questionnaires (the Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36) for assessing quality of life
Full Information
NCT ID
NCT01768104
First Posted
January 5, 2013
Last Updated
January 11, 2013
Sponsor
Nanfang Hospital, Southern Medical University
1. Study Identification
Unique Protocol Identification Number
NCT01768104
Brief Title
ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors
Official Title
Endoscopic Submucosal Tunnel Dissection Versus Video-assisted Thoracoscopic Surgery for Upper Gastrointestinal Submucosal Tumors: a Prospective Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2011
Overall Recruitment Status
Unknown status
Study Start Date
December 2011 (undefined)
Primary Completion Date
December 2013 (Anticipated)
Study Completion Date
December 2013 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nanfang Hospital, Southern Medical University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the efficacy and safety of endoscopic submucosal tunnel dissection (ESTD) compared with video-assisted thoracoscopic surgery (VATS) in the treatment of upper gastrointestinal submucosal tumors.
Detailed Description
Most upper gastrointestinal submucosal tumors (SMTs), especially the gastrointestinal stromal tumors (GISTs) and leiomyoma, are regarded as benign if they are less than 3cm in size. Thus, it has been suggested that patients should receive periodic endoscopic follow-up in case of gradual changes in size; however this can be stressful and troublesome for patients. Nevertheless, some of these tumors do have a malignant potential, and management by periodic endoscopic surveillance may lead to delayed diagnosis of malignancy. Therefore, it is necessary to remove the SMTs.
To date, several approaches have been used for the treatment of upper gastrointestinal SMTs, including open, thoracoscopic and laparoscopic surgery, and endoscopic approaches such as band ligation, endoscopic submucosal dissection (ESD), and endoscopic full-thickness resection (EFR). However, the surgical approaches are invasive with a longer hospital stay and greater cost, while the endoscopic approaches were limited by technical difficulty, incomplete resections and risk of perforation.
Recently, the technique of peroral endoscopic myotomy (POEM) for esophageal achalasia was introduced, a procedure in which a submucosal tunnel is created to expose and dissect the circular muscle of the esophagus. Inspired by the POEM approach, we have successfully used a similar method, endoscopic submucosal tunnel dissection (ESTD), to resect SMTs in upper gastrointestinal.
However, the long-term efficacy and safety of ESTD were not determined, and there was no prospective study compared the ESTD with other conventional approaches. Therefore, we plan to conduct this prospective randomized controlled trial, aim to determine the efficacy and safety of ESTD, compared with the pneumatic dilation, in the treatment of upper gastrointestinal SMTs originating from the muscularis propria layer .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Upper Gastrointestinal Submucosal Tumors (SMTs), Gastrointestinal Stromal Tumors (GISTs), Leiomyoma
Keywords
upper gastrointestinal submucosal tumors, SMTs, Gastrointestinal stromal tumors, GISTs, Leiomyoma, Endoscopic submucosal tunnel dissection, ESTD, Submucosal tunneling endoscopic resection, STER, Submucosal endoscopic tumor resection, SET
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ESTD
Arm Type
Experimental
Arm Description
Endoscopic submucosal tunnel dissection (ESTD) for patients with upper gastrointestinal submucosal tumors (SMTs)
Arm Title
VATS
Arm Type
Active Comparator
Arm Description
Video-assisted thoracoscopic surgery (VATS) for patients with upper gastrointestinal submucosal tumors (SMTs)
Intervention Type
Procedure
Intervention Name(s)
ESTD
Other Intervention Name(s)
Endoscopic submucosal tunnel dissection (ESTD), Submucosal tunneling endoscopic resection (STER), Submucosal endoscopic tumor resection (SET)
Intervention Description
A 2-cm longitudinal mucosal incision was made, approximately 5cm proximal to the submucosal tumor (SMTs).
Submucosal dissection was done, creating a submucosal tunnel until the tumor was visible.
Dissection was done along the margin of the tumor.
After the tumor had been removed, the potential bleeding area in the tunnel was coagulated.
Endoclips were used to close the entry of the submucosal tunnel.
(Gong W et al. ESTD for upper gastrointestinal submucosal tumors… Endoscopy 2012; 44: 231-235)
Intervention Type
Procedure
Intervention Name(s)
VATS
Other Intervention Name(s)
Video-assisted thoracoscopic surgery, Video-thoracoscopic enucleation
Intervention Description
General anesthesia with double lumen intubation.
Three to four cameras or working ports are placed over the chest wall.
After the lesion is visualized by thoracoscopy, the mediastinal pleura over the tumor is incised longitudinally by an endoscopic hook electrocauterizer.
The mass is exposed after the overlying muscle is split longitudinally.
The retracting suture is placed over the mass and then meticulously dissect the plane between the mass and the submucosal layer. The integrity of the mucosa must be checked.
The muscle layer is re-approximated and a chest tube is place through one of the ports.
(Luh et al. World Journal of Surgical Oncology 2012, 10:52)
Primary Outcome Measure Information:
Title
En bloc resection
Description
The En bloc resection was defined as a one-piece resection of the entire lesion without fragmentation
Time Frame
During the operation
Secondary Outcome Measure Information:
Title
Curative resection
Description
The curative resection was defined as the resected specimen with vertical and lateral margins free of neoplasia in pathological diagnosis.
Time Frame
From date of randomization until the date of pathological diagnosis, an expected average of 7 days
Title
Procedure related complication
Description
Perforation, Delayed bleeding, Pneumothorax, Subcutaneous emphysema, Anastomotic leak, etc.
Time Frame
From date of operation until the occurrence of the procedure related complication, which most occur within 7 days after operation, assessed up to 2 years
Title
Short-term morbidity
Description
Any cause death
Time Frame
From date of randomization until the date of death from any cause, assessed up to 3 months
Title
Local recurrence
Description
Local recurrence was defined as endoscopic or histological diagnosis of cancer at the resected site in follow-up
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years
Title
Quality of life
Description
Patients will complete the quality-of-life questionnaires (the Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36) for assessing quality of life
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Between 18 and 75 years of age
Patient with upper gastrointestinal submucosal tumor
Signed informed consent
Exclusion Criteria:
Severe cardio-pulmonary disease or other serious disease leading to unacceptable surgical risk
Endoscopic ultrasound (EUS) or CT signs of metastasis
Mega-oesophagus (greater than 7 cm) or Oesophageal diverticula in the distal oesophagus
Previous oesophageal or gastric surgery
Pregnancy or lactation women, or ready to pregnant women
Not capable of filling out questionnaires
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wei Gong, M.D.
Phone
+86 15820290385
Email
gwei203@yahoo.com.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wei Gong, M.D.
Organizational Affiliation
Department of Gastroenterology, Nanfang Hospital of Southern Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nanfang Hospital of Southern Medical University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510515
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaobing Cui, M.D.
Phone
+86 13631312723
Email
xbing119@gmail.com
12. IPD Sharing Statement
Citations:
PubMed Identifier
22354823
Citation
Gong W, Xiong Y, Zhi F, Liu S, Wang A, Jiang B. Preliminary experience of endoscopic submucosal tunnel dissection for upper gastrointestinal submucosal tumors. Endoscopy. 2012 Mar;44(3):231-5. doi: 10.1055/s-0031-1291720. Epub 2012 Feb 21.
Results Reference
background
PubMed Identifier
22543150
Citation
Zhao Y, Cai K, Liu D, Wu H, Xiong G, Wang H, Huang Z, Cai R, Wu X. [Video-assisted thoracoscopic removal of esophageal leiomyomas with intraoperative tumor location by endoscopy]. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Apr;32(4):586-8. Chinese.
Results Reference
background
Links:
URL
http://www.nfyy.com/
Description
Homepage of Nanfang Hospital of Southern Medical University
URL
http://www.xhbnet.com/
Description
Homepage of Department of Gastroenterology, Nanfang Hospital of Southern Medical University
Learn more about this trial
ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors
We'll reach out to this number within 24 hrs